Trials / Completed
CompletedNCT07329101
Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD · Industry
- Sex
- All
- Age
- 12 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single arm, and open-label phase I study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VC005 | VC005 with Local topical application |
Timeline
- Start date
- 2025-11-11
- Primary completion
- 2026-02-06
- Completion
- 2026-02-28
- First posted
- 2026-01-09
- Last updated
- 2026-04-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07329101. Inclusion in this directory is not an endorsement.